Live Breaking News & Updates on Seres therapeutics inc

Stay informed with the latest breaking news from Seres therapeutics inc on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Seres therapeutics inc and stay connected to the pulse of your community

Increases to Seres Therapeutics, Inc.'s (NASDAQ:MCRB) CEO Compensation Might Cool off for now

Key Insights Seres Therapeutics' Annual General Meeting to take place on 4th of April CEO Eric Shaff's total...

A-look-at-seres-therapeutics-inc , Has-seres-therapeutics-inc , Seres-therapeutics-inc , Seres-therapeutics ,

11 Oversold Healthcare Stocks To Buy Right Now

In this article, we will be taking a look at 11 oversold healthcare stocks to buy right now. To skip our detailed analysis of the healthcare sector, you can go directly to see the 5 Oversold Healthcare Stocks To Buy Right Now. The Healthcare Sector: The New 2024 Idea? The healthcare sector has been popular […]

Rockville , Maryland , United-states , New-york , Florida , Delray-beach , Highbridge , California , Seres-therapeutics-inc , Abbvie-inc , Petmed-express-inc

Seres Therapeutics, Inc. (NASDAQ:MCRB) Receives $13.20 Average Target Price from Analysts

Shares of Seres Therapeutics, Inc. (NASDAQ:MCRB – Get Free Report) have earned a consensus rating of “Moderate Buy” from the five ratings firms that are covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 1 year […]

Switzerland , Swiss , Seres-therapeutics-company-profile , Blackrock-inc , Metlife-investment-management , York-mellon-corp , Seres-therapeutics-inc , Swiss-national-bank , Jpmorgan-chase-co , Nasdaq , Seres-therapeutics

Seres Therapeutics, Inc. (NASDAQ:MCRB) Given Average Rating of "Moderate Buy" by Analysts

Seres Therapeutics, Inc. (NASDAQ:MCRB – Get Free Report) has earned an average rating of “Moderate Buy” from the five research firms that are currently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating on the company. The average twelve-month […]

Canada , Seres-therapeutics-inc , E-fund-management-co , Proshare-advisors , Royal-bank , Fund-management-co , Nasdaq , Pricet-rowe-associates-inc , Seres-therapeutics , Get-free-report , Marketbeat-ratings

Seres Therapeutics to Host Fourth Quarter 2023 Financial Results and Operational Progress Conference Call and Webcast on March 5, 2024

Seres Therapeutics to Host Fourth Quarter 2023 Financial Results and Operational Progress Conference Call and Webcast on March 5, 2024
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Cambridge , Cambridgeshire , United-kingdom , Health-science , Nasdaq , Seres-therapeutics-inc ,

Seres Therapeutics to Participate in Cowen 44th Annual Healthcare Conference

Seres Therapeutics to Participate in Cowen 44th Annual Healthcare Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Cambridge , Cambridgeshire , United-kingdom , Eric-shaff , Seres-therapeutics-inc , Health-care-conference-on , Nasdaq , Health-science , Chief-executive-officer , Seres-therapeutics , Annual-health-care-conference ,

Seres Therapeutics Announces the Appointment of Marella Thorell as Chief Financial Officer and the Retirement of David Arkowitz

Seres Therapeutics, Inc. , a leading microbiome therapeutics company, announced today that Marella Thorell will join as Executive Vice President and Chief Financial Officer , as of March 25th,...

Palladio-biosciences , Eric-shaff , David-arkowitz , Marella-thorell , Evelo-biosciences , Centessa-pharmaceuticals , Health-science , Nasdaq , Exchange-commission , Seres-therapeutics-inc , Seres-therapeutics , Executive-vice-president

Seres Therapeutics Announces the Appointment of Marella Thorell as Chief Financial Officer and the Retirement of David Arkowitz

Seres Therapeutics Announces the Appointment of Marella Thorell as Chief Financial Officer and the Retirement of David Arkowitz
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

Cambridge , Cambridgeshire , United-kingdom , Palladio-biosciences , David-arkowitz , Evelo-biosciences , Eric-shaff , Marella-thorell , Nasdaq , Seres-therapeutics-inc , Exchange-commission , Centessa-pharmaceuticals

Analysts Set Seres Therapeutics, Inc. (NASDAQ:MCRB) Price Target at $13.20

Seres Therapeutics, Inc. (NASDAQ:MCRB – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the five analysts that are presently covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold rating and four have issued a buy rating on the company. The average twelve-month target […]

Canada , Royal-bank , Coppell-advisory-solutions , Bridgefront-capital , Seres-therapeutics-inc , Nasdaq , Raymond-james-associates , Seres-therapeutics-company-profile , Seres-therapeutics , Get-free-report , Marketbeat-ratings

Seres Therapeutics (MCRB):Promising IP Overshadowed By Stock Dilution Risks

Seres Therapeutics (MCRB):Promising IP Overshadowed By Stock Dilution Risks
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Massachusetts , United-states , Canada , Cambridge , Cambridgeshire , United-kingdom , Nasdaq , Seres-therapeutics-inc , Health-science , Nestle , Seres-therapeutics-investor-presentation